MXL vs SRPT · rev $360.5M vs rev $1.90B
MaxLinear Inc (MXL) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
MaxLinear Inc (MXL) is a semiconductors company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported MXL revenue for 2024-12-31 was $360.5M. Net income was -$245.2M. Revenue was down 48.0% from 2023-12-31 to 2024-12-31. MXL currently screens at market cap $7.42B.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
MXL currently screens at market cap $7.42B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the MXL and SRPT stock pages for the full models.
Not investment advice.